Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The review suggests there's no agreed treatment for Frontal Fibrosing Alopecia, but hydroxychloroquine and 5a-reductase inhibitors are most effective. New treatments like platelet-rich plasma and LED light could help if standard treatments fail.

Treatment with 5α-reductase inhibitors is linked to a delay in prostate cancer diagnosis and may affect survival rates.

Certain amino acids in 5AR1 and 5AR2 are crucial for binding and resistance to Finasteride.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.

5-Alpha reductase inhibitors help treat enlarged prostate but may cause sexual side effects.

5ARIs like finasteride can help prevent prostate cancer and treat BPH, but guidelines should be updated to reflect this.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

5 Alpha-Reductase Inhibitors reduce the effects of testosterone by blocking its conversion into a stronger form.

5ARIs lower PSA levels, but other tests are needed to avoid missing aggressive prostate cancer.

5α-reductase enzymes are crucial in certain disorders, and while treatment advances exist, more research on SRD5A3 is needed.

5α-reductase inhibitors are effective for treating hair loss in androgenetic alopecia.

Some treatments can stabilize Frontal Fibrosing Alopecia, but more research is needed to find effective treatments, and hair transplants often fail.

Combination therapy, especially with finasteride, is effective for treating frontal fibrosing alopecia.

Standard treatment for congenital erythropoietic porphyria was ineffective over five years.

5 alpha reductase inhibitors can cause sexual, cognitive, and muscle side effects, and may slightly increase aggressive cancer risk.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

5-alpha reductase inhibitors help with benign prostatic hyperplasia but don't cure it, and more research is needed.

Long-term use of 5α-reductase inhibitors may improve survival in men with kidney cancer.

Taking 5-ARI before prostate laser surgery may lead to more blood changes, longer surgery, and more urinary issues.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Intralesional corticosteroids and 5-alpha-reductase inhibitors are the best treatments for frontal fibrosing alopecia.

Photodynamic therapy successfully treated skin cancer in a 53-year-old woman.

5-Alpha Reductase Inhibitors are effective for male hair loss and some skin conditions, but their effectiveness in women and safety concerns require careful use.

Compound 4 is a promising treatment for hair loss with low toxicity.